News

A medication that secretes growth hormone is shown to reduce liver fat in an HIV-positive population, and investigators would like to see it used more widely.

What hurdles are companies facing in the pursuit of developing new antibiotics against multidrug-resistant organisms?

Results from a study at a Cincinnati hospital point to the importance of testing at-risk infants for HCV as the opioid crisis impacts prevalence of the infection.

H3N2, a particularly virulent strain of influenza, blew through Australia. Is it coming to the United States this fall and winter?

A new study points to an increased risk for infections in patients with PTSD.

Leaders from the WHO and various impacted countries met to assess the risks of the Ebola outbreak in the Democratic Republic of the Congo and the future of the outbreak response.

A group provides an overview of ongoing research and current approaches being evaluated for the prevention of tick-borne disease.

Helicobacter pylori resistance to clarithromycin more than doubled during the past 20 years, according to new research presented at UEG Week Barcelona 2019.

Kindergarten vaccination coverage is near the recommended 95%, but nonexempt holdouts, which could be addressed, can still lead to outbreaks.

A large majority of sepsis patients are pathogen-negative, yet empiric prescribing of antibiotics varies significantly from patient to patient.

Using a unique approach of targeting the stalk of the hemagglutinin, investigators are taking steps toward developing a universal influenza vaccine candidate.

Given a general rise in STD cases, clinicians treating ESRD may have to pay special attention to possible coinfections.

Eravacycline may be an option for patients with a history of C diff or those with a history of infections who are at risk for developing the infection.

Pooled analysis linked baseline demographics, including lower CD4 count, higher HIV-1 RNA, no history of injection drug use, female sex, and black race, to weight gain following ART initiation.

The ECDC 2019 plan to address multi- and extensively-drug resistant gonorrhea has been released.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of October 13, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Angela Campbell, MD, MPH, details a study on influenza vaccine effectiveness in children with respiratory illness.

Dissemination of fungi, including Cryptococcus neoformans and Candida albicans, is limited by liver macrophages, according to a new study from the University of Maryland.

The latest report from the CDC shows that preventable infections are on the rise nationally. Particularly hard hit are women, young people, minority groups, and infants exposed to syphilis.

Although the overall mortality rate for HCV has declined, clinicians will have to focus on individuated factors to address lingering barriers.

The approval marks the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from the flu.

While infectious disease consultations reduced the amount of antibiotics used for patients, it only affected C diff rates at 1 of 3 hospitals in the study.

The committee voted 14 to 2 that substantial evidence of efficacy and safety for cefiderocol was provided for the treatment of cUTI including pyelonephritis in patients with limited or no alternative treatment options.

A patient was evaluated for Ebola in a Swedish hospital. Here's what we should take away from it.

Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, spoke to Vaibhav Singh from Circle of Life about Zevac, a tool that aims to help clinicians make more informed prescribing decisions.

NEJM study suggests testing everyone, regardless of symptoms, can reduce prevalence.